Medical device technology provider Therma Bright (TSX.V: THRM) (OTC: THRBF) is developing an innovative pain relief therapy that utilizes its thermal therapy technology in combination with medical grade cannabis or cannabidiol (“CBD”) from hemp in the form of a cream or gel. A recent article discussing the company reads, “In October, Therma Bright revealed that it is also developing testing for a hemp cannabidiol (CBD)-based pain relief therapy that will use creams, gels or salves in concert with its thermal-generation products to target various forms of general or chronic pain such as back pain, arthritic pain and other orthopedic concerns. The company announced its first prototype in December. … Therma Bright’s attention to such a variety of skin care concerns positions it well within the cosmeceuticals market, which is expected to grow at a CAGR of 8.21 percent between 2017 and 2023, resulting in a worldwide market valued at $72.99 billion overall (http://cnw.fm/KC06a).”
To view the full article, visit http://cnw.fm/FEq9T
About Therma Bright Inc.
Therma Bright is a progressive medical device technology company focused on providing consumers with quality medical devices that address their dermatological needs. Clear and healthy skin for all is at the core of the company’s philosophy as is the belief that such outcomes should not be a privilege for only those who can afford costly procedures and treatments. The company’s breakthrough proprietary technology delivers effective, non-invasive and pain free skin care. For more information, visit the company’s website at www.ThermaBright.com.
More from CannabisNewsBreaks
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com